By Lida Mattman
Ph.D. in Immunology from Yale University


Call (530) 541-7200 or 
Place Your Order Online

448 Pages
3rd Edition

See Enlarged Back Cover

Dr. Mattman's Work Leads to Medical Breakthrough
(Excerpt from The Top 10 Lyme Disease Treatments)

The Marshall Protocol is perhaps the most significant breakthrough in Lyme Disease treatment since Doug MacLean discovered in the 1980s how to employ a homemade rife machine (see Chapter 5) to heal his own Lyme infection. The reason the Marshall Protocol is so significant is that it addresses an aspect of the Lyme Disease complex which no other treatment, protocol, supplement or herb can even come close to touching. The discoveries that led Trevor Marshall, Ph.D., to develop the Marshall Protocol have uncovered and exposed a critical part of the process which Borrelia Burgdorferi uses to establish and maintain infection in the host. The Marshall Protocol is the only known therapy which addresses this aspect of the bacterial survival process. If you take the Marshall Protocol out of the Lyme Disease treatment toolbox, there is no comparable tool to replace it. 

The protocol builds on the work of Dr. Lida Mattman, one of the most influential medical scientists in modern history. With a master's degree in virology from the University of Kansas and a Ph.D. in immunology from Yale University , Lida Mattman has revolutionized the study of infectious disease and established the foundation for decades of progress in science and medicine. A 1998 nominee for the Nobel Prize in Medicine, Mattman found that a certain type of bacteria lacking a cell wall (known as cell-wall-deficient, variant, or L-form bacteria) are not only very common but are also the root cause of multiple health conditions that have baffled medical scientists for years. The presence of cell-wall-deficient pathogens in the human body is extremely difficult to detect and has thus been largely ignored by conventional medicine. 

Dr. Mattman's studies have forced hundreds of physicians and researchers to accept the fact that this elusive and highly complicated class of bacteria is responsible for many previously-misunderstood ailments. Interestingly, Mattman's research findings bear a striking resemblance to the conclusions about microorganisms drawn by Dr. Royal Raymond Rife himself. 

Although her breakthrough discoveries caused a light-speed acceleration in the field of bacteriology, no one has been able to figure out exactly what to do about the cell-wall-deficient bacteria identified by Dr. Mattman. We know they are there, and we know they cause many diseases considered untreatable or incurable by conventional medicine, but getting rid of them is a different story. 

Fortunately, there is a handful of brilliant researchers who are currently studying these pathogens and are discovering ways to attack cell-wall-deficient bacteria, destroy them, and thereby heal incurable diseases. Trevor Marshall, Ph.D., is one such researcher. After failing to gain benefit from conventional treatment for his own affliction with sarcoidosis (a multi-system disorder characterized in affected organs by inflammatory lesions), Marshall was compelled to take a closer look at the pathogenesis of chronic disease. His research conclusions were very similar to those reached by Dr. Mattman: a surprisingly long list of chronic diseases are actually caused by cell-wall-deficient bacteria. Sarcoidosis and Lyme Disease, for example, share this root cause. If you are confused because you thought Lyme Disease was caused by spirochetes, not cell-wall-deficient bacteria, keep reading, we will answer that question. 

Decades of studies by Dr. Marshall led him beyond the ability to merely identify cell-wall-deficient bacteria and their role in various disease processes. In developing the protocol which bears his name, he has created the means to actually counter their bacterial activity. The Marshall Protocol is a ground-breaking method of killing cell-wall-deficient bacteria in the human body and ultimately curing the previously untreatable diseases this pathogen causes. After Marshall employed his discoveries to treat sarcoidosis and heal himself, he went on to establish The Autoimmunity Research Foundation through which he collaborates with physicians and researchers around the world to help chronically ill people recover from various afflictions. Marshall has bridged the gap between simple awareness of the existence of cell-wall-deficient bacteria and knowledge of how to eradicate them.


Nobel Prize Nominee Lida Mattman, Ph.D., is world renowned as the leading expert on cell wall deficient bacteria.

With 448 pages, weighing 2.1lbs, this book is not only the largest, but also the first, and most extensive, textbook on stealth pathogens. 

Key features of the book include:

  • 79 color photographs illustrating the various types of bacteria under the microscope

  • A table of diseases caused by L variants

  • A table of organisms that are virulent in L stage

Published by Oakland University, California, this comprehensive text covers the following key topics:

  • Definitions

  • Comparison of mycoplasma, rickettsia, and other CWD forms

  • Disclosures by electron microscope

  • Public health and nosocomial facets

  • Septicemina and cardiopathies

  • Immunology

  • Joint and bone disease

  • Much more!

Publisher's Description:

Numerous infectious diseases are described as idiopathic, meaning that "the cause is a complete mystery." For many idiopathic diseases, the causes become clear when certain techniques are applied to the patient's blood or other tissues. Cell Wall Deficient Forms: Stealth Pathogens, Third Edition describes these techniques. 

In the case of tuberculosis, a disease that has recently regained importance because the strains have acquired antibiotic resistance, the book describes a method that is widely used abroad. This method typically renders the diagnosis within 72 hours. 

The book examines a plethora of issues and provides answers to the following questions:

  • What organisms should be added to childhood vaccines, especially for boys?

  • What bacteria in its pleomorphic state is found in direct smears of synovial fluid of rheumatoid arthritis cases?

  • In which chronic diseases (presently considered as being of unknown origin) is an acid-fast organism routinely found in smears of 72 hour blood cultures?

  • Which "bacterium" has a life cycle in the human erythrocyte as complex as that of Plasmodium malaria?

  • Which common pathogen's L Form can permanently damage myocardium mammaliam?

Cell Wall Deficient Forms: Stealth Pathogens, Third Edition discloses significant aspects of microbiology, aspects that are not taught, and which go unrecognized in the clinical laboratory.

Order the Book:

448 Pages
3rd Edition

Call (530) 541-7200 or 
Place Your Order Online




 About Dr. Mattman:

Lida H Mattman, PhD, has spent seven decades studying the different forms that bacteria can take. Her contributions to medical science can be summarized best by noting that in 1998 she was nominated for the highest honor attainable in her profession: The Nobel Prize in Medicine. Professor Mattman graduated with a M.S. in Virology from Univ. of Kansas and a Ph.D. in Immunology from Yale. She has taught Immunology, Microbiology, Bacteriology, Virology, Pathology, and for 35 years worked in these fields at various schools and institutions including Harvard Univ., Howard Hughes Institute, Oakland Univ. and Wayne State Univ. where she is Professor Emeritus. She is currently working for the Nelson Medical Research Institute studying the relationship between spirochetes involved in MS, Lyme disease, and ALS.

BioMed Publishing Group

P.O. Box 9012

South Lake Tahoe, CA 96150

Contact Us

(801) 925-2411

Disclaimer: The products offered on this web site are intended for informational and educational purposes only and are not intended to prevent, diagnose, treat, or cure disease.  The statements on this web site have not been evaluated by the United States Food and Drug Administration. If you have a medical problem see a licensed physician. 

Copyright 2007 BioMed   |   Advertise with us